Clinical trials
Completed Phase 1/2 Leukemia, Lymphocytic, Chronic, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
117 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 4 |
| 2002 | 5 |
| 2003 | 8 |
| 2004 | 5 |
| 2005 | 10 |
| 2007 | 6 |
| 2008 | 7 |
| 2009 | 7 |
| 2010 | 7 |
| 2011 | 6 |
| 2012 | 8 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 117 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 12 |
| M.D. Anderson Cancer Center | 10 |
| Mayo Clinic | 6 |
| National Cancer Institute (NCI) | 6 |
| Pharmacyclics LLC. | 4 |
| Arbeitsgemeinschaft medikamentoese Tumortherapie | 3 |
| German CLL Study Group | 3 |
| AbbVie | 2 |
| BeiGene | 2 |
| Celgene | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 117 |
| Lymphoma, Follicular | 49 |
| Lymphoma, Non-Hodgkin | 49 |
| Lymphoma, Mantle-Cell | 48 |
| Lymphoma, B-Cell, Marginal Zone | 44 |
| Leukemia | 40 |
| Lymphoma | 38 |
| Lymphoma, Large B-Cell, Diffuse | 37 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 35 |
| Hodgkin Disease | 34 |
Trials
Showing 1 to 25 of 117. Each trial links to its page on Pharma Observatory.
17 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.